Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for

The market expects ImmunoGen (IMGN) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2020. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a powerful factorThe market expects ImmunoGen (IMGN) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2020. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a powerful factorRead MoreStocks,InvestingStocks Feed